Tower Research Capital (TRC)’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$295K Buy
5,339
+5,108
+2,211% +$282K 0.01% 1436
2025
Q1
$11.2K Sell
231
-7,138
-97% -$345K ﹤0.01% 3560
2024
Q4
$284K Buy
7,369
+7,009
+1,947% +$271K 0.01% 1449
2024
Q3
$16.2K Sell
360
-14,316
-98% -$644K ﹤0.01% 3376
2024
Q2
$509K Buy
14,676
+14,354
+4,458% +$497K 0.01% 1323
2024
Q1
$9.32K Sell
322
-11,437
-97% -$331K ﹤0.01% 3866
2023
Q4
$270K Buy
11,759
+4,037
+52% +$92.6K ﹤0.01% 1854
2023
Q3
$129K Buy
7,722
+4,604
+148% +$76.8K ﹤0.01% 1777
2023
Q2
$86.1K Buy
3,118
+1,460
+88% +$40.3K ﹤0.01% 2119
2023
Q1
$38K Sell
1,658
-89
-5% -$2.04K ﹤0.01% 2756
2022
Q4
$19K Sell
1,747
-25,407
-94% -$276K ﹤0.01% 3183
2022
Q3
$229K Sell
27,154
-23,569
-46% -$199K ﹤0.01% 1796
2022
Q2
$401K Buy
50,723
+44,540
+720% +$352K 0.01% 1275
2022
Q1
$146K Sell
6,183
-2,652
-30% -$62.6K ﹤0.01% 1961
2021
Q4
$302K Sell
8,835
-3,298
-27% -$113K 0.01% 1478
2021
Q3
$215K Buy
12,133
+10,087
+493% +$179K 0.01% 1756
2021
Q2
$92K Buy
2,046
+499
+32% +$22.4K ﹤0.01% 2499
2021
Q1
$40K Sell
1,547
-9,624
-86% -$249K ﹤0.01% 3319
2020
Q4
$225K Buy
11,171
+9,834
+736% +$198K 0.01% 1615
2020
Q3
$26K Sell
1,337
-1,551
-54% -$30.2K ﹤0.01% 3776
2020
Q2
$51K Buy
+2,888
New +$51K ﹤0.01% 3032
2020
Q1
Sell
-2,899
Closed -$20K 3721
2019
Q4
$20K Buy
+2,899
New +$20K ﹤0.01% 1922
2019
Q3
Sell
-75
Closed -$1K 4436
2019
Q2
$1K Buy
+75
New +$1K ﹤0.01% 3474
2019
Q1
Sell
-7,128
Closed -$48K 4181
2018
Q4
$48K Buy
7,128
+7,007
+5,791% +$47.2K ﹤0.01% 1314
2018
Q3
$1K Sell
121
-926
-88% -$7.65K ﹤0.01% 3610
2018
Q2
$7K Sell
1,047
-247
-19% -$1.65K ﹤0.01% 2962
2018
Q1
$11K Buy
+1,294
New +$11K ﹤0.01% 2434
2017
Q4
Sell
-1,750
Closed -$31K 3968
2017
Q3
$31K Buy
+1,750
New +$31K ﹤0.01% 2415
2017
Q2
Sell
-656
Closed -$9K 3365
2017
Q1
$9K Buy
+656
New +$9K ﹤0.01% 1862